Several Bcl2 proteins are downstream of commonly activated RAS/BRAF/MAPK and PI3K/Akt signaling pathways which play an important role in tumor initiation and maintenance of melanoma specific CSCs compartment [146]. This evidence concerns the gene BCL2 and melanoma.